Titlebook: Natural Products as Source of Molecules with Therapeutic Potential; Research & Developme Valdir Cechinel Filho Book 2018 Springer Nature Sw

ODDS

書目名稱Natural Products as Source of Molecules with Therapeutic Potential影響因子(影響力)




書目名稱Natural Products as Source of Molecules with Therapeutic Potential影響因子(影響力)學(xué)科排名




書目名稱Natural Products as Source of Molecules with Therapeutic Potential網(wǎng)絡(luò)公開度




書目名稱Natural Products as Source of Molecules with Therapeutic Potential網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Natural Products as Source of Molecules with Therapeutic Potential被引頻次




書目名稱Natural Products as Source of Molecules with Therapeutic Potential被引頻次學(xué)科排名




書目名稱Natural Products as Source of Molecules with Therapeutic Potential年度引用




書目名稱Natural Products as Source of Molecules with Therapeutic Potential年度引用學(xué)科排名




書目名稱Natural Products as Source of Molecules with Therapeutic Potential讀者反饋




書目名稱Natural Products as Source of Molecules with Therapeutic Potential讀者反饋學(xué)科排名

Conquest

Springer Nature Switzerland AG 2018

anus928

積極詞匯

investigate

Plant Products with Antifungal Activity: From Field to Biotechnology Strategies,view attempts to summarize the current status of botanical screening efforts, as well as in vitro and in vivo studies on antifungal activity of plant products. Despite the currently non-uniform regulatory framework in all the states, the plant-derived products are increasingly in demand for their ef

cauda-equina

Optic-Disk

Eclampsia

Syntheses of Asymmetrically Substituted Pyrans of Natural Origin,y and medicine. The survey starts with various modes of pyran-focused cyclizations, with many examples of hetero-Diels-Alder cycloaddition reactions in which configuration of all stereogenic centers is controlled. Another method of pyran synthesis which is of general use and great importance consist

水汽

Virtual Screening for the Discovery of Active Principles from Natural Products,iting field of science. It gives a brief introduction into the field of cheminformatics and presents different virtual screening strategies implemented in pharmacognostic workflows to point out opportunities and challenges in NP-based drug discovery.

Prologue